How should abdominal bloating be evaluated and managed?

Evaluation and Management of Abdominal Bloating

Start with a focused clinical history to differentiate between primary bloating/distension and bloating associated with other disorders (IBS, constipation, functional dyspepsia), then pursue an algorithmic diagnostic approach based on Rome IV criteria and associated symptoms, reserving invasive testing only for alarm features. 1

Initial Clinical Assessment

Begin by determining whether the patient meets Rome IV criteria for functional abdominal bloating/distension as a primary disorder, or if bloating occurs alongside IBS, functional constipation, or functional dyspepsia 1. Key distinction: primary functional bloating should NOT fulfill criteria for these other disorders 1.

Critical History Points:

• Constipation presence: Determines need for anorectal manometry to evaluate pelvic floor dysfunction 1
• Excessive belching: Suggests supragastric belching or aerophagia requiring different management 1
• Nausea/vomiting: May warrant gastric emptying studies for gastroparesis 1
• Alarm features: Weight loss >10%, GI bleeding, family history of IBD, or recent symptom worsening mandate imaging and endoscopy 1

Diagnostic Algorithm

First-Line Evaluation (No Alarm Features):

1. Rule out food intolerances 1

• Start with 2-week dietary restriction trial - this is the simplest and most cost-effective approach 1
• Target carbohydrate enzyme deficiencies (lactose, fructose, sucrose) and artificial sweeteners
• Fructose intolerance affects 60% of DGBI patients, lactose 51% 1
• Reserve breath testing (hydrogen/methane/CO2) only for patients who fail dietary restriction 1

2. Screen for celiac disease 1

• Obtain tissue transglutaminase IgA and total IgA levels
• If positive, confirm with small bowel biopsy before treatment
• Involve gastroenterology dietitian for gluten-free diet management 1

3. Assess for constipation-related bloating 1

• If constipation present: Obtain anorectal manometry to diagnose pelvic floor dyssynergia 1
• This is critical as pelvic floor disorders respond to specific biofeedback therapy 1

4. Consider SIBO only in high-risk patients 1

• Risk factors: chronic watery diarrhea, malnutrition, structural bowel disease (cystic fibrosis, Parkinson's)
• Use glucose or lactulose breath testing or small bowel aspirates 1
• Do NOT routinely test for SIBO in uncomplicated bloating 1

Testing to AVOID:

• Do NOT order gastric emptying studies routinely - only if nausea/vomiting present 1
• Do NOT order whole gut motility studies unless treatment-refractory with multiple GI symptoms 1
• Avoid imaging/endoscopy unless alarm features, abnormal exam, or recent worsening 1

Treatment Approach

Dietary Management:

Low-FODMAP diet under dietitian supervision 1

• Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols restriction
• Critical caveat: Must involve gastroenterology dietitian to prevent nutritional deficiencies 1
• Patients often self-impose overly restrictive diets that worsen outcomes 2

Pharmacologic Therapy:

1. If constipation present:

• Treat the constipation first - constipation medications should be considered for bloating when constipation symptoms exist 1
• Options include secretagogues (linaclotide, plecanatide, lubiprostone, tenapanor) 3

2. Central neuromodulators (antidepressants):

• Reduce visceral hypersensitivity, raise sensation threshold, improve psychological comorbidities 1
• Use regardless of diagnostic correlates when bloating is severe 1

3. Avoid probiotics:

• Probiotics should NOT be used to treat abdominal bloating and distension 1
• This is explicit AGA guidance despite widespread patient use

Behavioral Interventions:

Brain-gut behavioral therapies 1

• Cognitive behavioral therapy
• Diaphragmatic breathing (especially for abdominophrenic dyssynergia)
• Hypnotherapy
• Can be used in combination with neuromodulators 1

Biofeedback therapy:

• Effective when pelvic floor disorder identified 1
• This is why anorectal testing matters in constipation-associated bloating

Common Pitfalls:

1. Over-testing: Most patients don't need imaging, endoscopy, or motility studies 1
2. Skipping dietary trial: Going straight to breath testing wastes resources 1
3. Missing pelvic floor dysfunction: Constipation-related bloating needs anorectal testing 1
4. Prescribing probiotics: No evidence supports this despite patient demand 1
5. Inadequate dietary supervision: Self-directed restrictive diets cause harm 1, 2

Special Considerations:

Visceral hypersensitivity is common in IBS patients - they experience symptoms from carbohydrate malabsorption that others tolerate 1. This explains why identical dietary triggers affect patients differently and why neuromodulators targeting sensation thresholds are effective 1.

Abdominophrenic dyssynergia presents as distension worse after meals, not explained by increased intestinal gas 1. Treat with diaphragmatic breathing and central neuromodulators 1.